23.06.2025, 12:59

Polpharma to invest $62.6 mln in expansion of ChimPharm plant in Kazakhstan

ASTANA. June 23 (Interfax-Kazakhstan) - Polpharma Group will invest $62.6 million to expand the production capacity of its subsidiary ChimPharm JSC (SANTO), a pharmaceutical plant located in Shymkent, the press service of Kazakhstan’s government said in a Monday statement.

To read the full news articles, Subscribe.

08:37PM
Turkmenistan ready to help settle Mideast situation using all diplomatic means - Foreign Ministry

08:35PM
Dozens of countries ask Turkmenistan to help their citizens flee Iran

07:23PM
Role of CIS Antiterrorism Center to grow amid new hybrid threats - Lukashenko

07:18PM
CSTO CFM to discuss impact of int’l situation on member states' security

07:04PM
Tokayev signs amnesty law affecting over 15,000 convicts

06:51PM
Over 800 law enforcement officers perished during Kazakhstan's independence years – President

06:46PM
Kazakhstan denies reports of drone launches toward Russia

06:37PM
Penal system reform to focus on rehabilitating convicts, not just isolating them – Tokayev

06:24PM
Kazakhstan achieves significant results in fighting crime, but problems remain – Tokayev

05:46PM
Air Astana cancels flights to Doha, Dubai on June 24 amid escalation of Middle East conflict

05:36PM
Kazakhstan to receive first Stadler passenger railroad cars by end of 2025